Pharmacological Treatment Targeting Endotypic Traits of Obstructive Sleep Apnea
Conditions: Obstructive Sleep Apnea of Adult Interventions: Drug: Atomoxetine 80mg combined with oxybutynin 5mg; Drug: Venlafaxine 37.5mg; Drug: Atomoxetine 80mg combined with trazodone 100mg; Drug: Placebo Sponsors: China Medical University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder
Conditions: Major Depression Disorder Interventions: Drug: Toludesvenlafaxine hydrochloride sustained-release tablets; Drug: Venlafaxine hydrochloride sustained-release tablets Sponsors: First Affiliated Hospital of Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)
Conditions: Major Depressive Disorder; Bipolar Affective Disorder, Currently Depressed, Moderate Interventions: Drug: Venlafaxine Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 14, 2023 Category: Research Source Type: clinical trials
REDucing Hot FLASHes in Women Using Endocrine Therapy.
Conditions: Breast Cancer; Hot Flash Due to Medication Interventions: Drug: Oxybutynin; Drug: Venlafaxine Sponsors: Reinier de Graaf Groep Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Condition: Hot Flashes Interventions: Drug: Fezolinetant; Drug: Paroxetine; Drug: Citalopram; Drug: Escitalopram; Drug: Desvenlafaxine; Drug: Venlafaxine; Drug: Gabapentin; Drug: Clonidine; Drug: Pregabalin; Drug: Oxybutynin; Drug: Any other SSRI/SNRI not already specified; Drug: Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above Sponsor: Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats
Conditions: Hot Flashes Interventions: Drug: Fezolinetant; Drug: Paroxetine; Drug: Citalopram; Drug: Escitalopram; Drug: Desvenlafaxine; Drug: Venlafaxine; Drug: Gabapentin; Drug: Clonidine; Drug: Pregabalin; Drug: Oxybutynin; Drug: Any other SSRI/SNRI not already specified; Drug: Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above Sponsors: Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
Condition: Bipolar Depression Interventions: Drug: Escitalopram; Drug: Sertraline; Drug: Duloxetine; Drug: Venlafaxine; Drug: Lithium; Drug: Lamotrigine; Drug: Valproate acid; Drug: Quetiapine Sponsors: Dr. Inge Winter; Westfälische Wilhelms-Universität Münster Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2023 Category: Research Source Type: clinical trials
